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Oxolinic acid (OA), a quinolone, inhibits the activity of DNA gyrase composed of GyrA and GyrB and shows
antibacterial activity against Burkholderia glumae. Since B. glumae causes bacterial seedling rot and grain rot
of rice, both of which are devastating diseases, the emergence of OA-resistant bacteria has important implica-
tions on rice cultivation in Japan. Based on the MIC of OA, 35 B. glumae field isolates isolated from rice seedlings
grown from OA-treated seeds in Japan were divided into sensitive isolates (OSs; 0.5 g/ml), moderately
resistant isolates (MRs; 50 g/ml), and highly resistant isolates (HRs; >100 g/ml). Recombination with gyrA
of an OS, Pg-10, led MRs and HRs to become OA susceptible, suggesting that gyrA mutations are involved in
the OA resistance of field isolates. The amino acid at position 83 in the GyrA of all OSs was Ser, but in all MRs
and HRs it was Arg and Ile, respectively. Ser83Arg and Ser83Ile substitutions in the GyrA of an OS, Pg-10,
resulted in moderate and high OA resistance, respectively. Moreover, Arg83Ser and Ile83Ser substitutions in
the GyrA of MRs and HRs, respectively, resulted in susceptibility to OA. These results suggest that Ser83Arg
and Ser83Ile substitutions in GyrA are commonly responsible for resistance to OA in B. glumae field isolates.
Burkholderia glumae-induced bacterial seedling rot and grain
rot are devastating diseases that affect rice cultivation in South-
east Asian countries such as Japan and Korea. In growing
seedlings, bacterial seedling rot is caused by a rapid increase in
B. glumae populations in the epidermis of the plumules (14).
After the rice seedlings are transplanted into paddy fields, the
pathogen is usually isolated from the lower leaf sheaths (15). It
can be found in the upper leaf sheaths, including the flag leaf
sheaths before the heading stage, although symptoms do not
appear on the leaf blades or leaf sheaths. It then invades the
flowering spikelets, multiplies rapidly, and finally causes bac-
terial grain rot (19).
Oxolinic acid (OA) treatment of rice seeds and spray appli-
cations to heading rice plants have a high efficacy in the control
of bacterial seedling rot and grain rot, respectively (14, 15). OA
is a quinolone derivative with antibacterial activity against
gram-negative bacteria, including B. glumae (13, 22, 37), and it
inhibits the proliferation of bacteria in the plumules of seed-
lings and the spikelets of heading rice plants (14, 19). OA con-
trol involving seed treatment and spray applications to heading
rice plants when combined with seed selection with salt solu-
tions has a significant influence on B. glumae infection cycles
and is highly efficacious in the control of these diseases (16).
Quinolones act by inhibiting the action of type II topoisom-
erase, DNA gyrase, and topoisomerase IV (25). DNA gyrase is
a tetrameric enzyme composed of two A subunits and two B
subunits, encoded by gyrA and gyrB, respectively (11, 35).
Topoisomerase IV is also an A2B2 enzyme and is composed of
ParC and ParE (23, 24), whose amino acid sequences share
similarity to those of GyrA and GyrB, respectively. The main
function of DNA gyrase is to catalyze the negative supercoiling
of DNA (21), whereas topoisomerase IV seems to be associ-
ated with decatenation of the daughter replicons (25). The tar-
gets of quinolones in gram-negative bacteria are different from
thoseingram-positivebacteria.Ingram-negativebacteriathetar-
get is DNA gyrase, whereas in gram-positive bacteria the target
is topoisomerase IV (32). Therefore, either gyrA or gyrB muta-
tions are responsible for the resistance of gram-negative bac-
teria. In addition, topoisomerase IV mutations can further in-
crease this level of resistance. Decreased quinolone uptake is also
involved in quinolone resistance and might be associated with
two factors, an increased impermeability of bacteria to quino-
lones or the overexpression of efflux pumps (32). In gram-
negative bacteria, such as Escherichia coli, Salmonella enterica
serovar Typhimurium, and Neisseria gonorrhoeae, the major
target of mutations is the gyrA gene (32). Most of the muta-
tions identified thus far are located in a small region in GyrA,
the quinolone resistance-determining region (QRDR) (40).
Recently, OA-resistant B. glumae was isolated from rice seed-
lings grown from OA-treated seeds (17). Because the conditions
for raising seedlings are suitable for the growth of seed-borne
bacteria, the growth of OA-resistant bacteria on rice plants can
eventually lead to bacterial seedling rot and grain rot and sig-
nificant production losses. OA-resistant B. glumae isolates ob-
tained in vitro have been characterized (17), and these isolates
also have a concomitant cross-resistance to other quinolones.
OA-resistant B. glumae isolates grow rapidly in seedlings and
rot the plants only when seeds are infested with a high density of
OA-resistant bacteria and then treated with OA. However, the
mechanisms of resistance to OA in B. glumae remain unclear.
* Corresponding author. Mailing address: Laboratory of Plant Pa-
thology and Biotechnology, Kochi University, 200 Monobe, Nankoku,
Kochi 783-8502, Japan. Phone: 81-88-864-5218. Fax: 81-88-864-5219.
E-mail: yhikichi@cc.kochi-u.ac.jp.
5613
In this study, the mechanisms of resistance to OA in B. glu-
mae field isolates were investigated. The results suggest that an
amino acid substitution at position 83 of GyrA is implicated in
OA resistance in field isolates, because among various OA-
resistant bacteria only those with a substitution in GyrA might
retain the ability to survive on rice plants.
MATERIALS AND METHODS
Bacterial strains, plasmids, and culture conditions. The bacterial strains and
plasmids used in the present study are listed in Table 1. B. glumae strains were
routinely grown in peptone-yeast medium (peptone, 5 g; yeast extract, 2 g; de-
ionized water, 1 liter; PY medium) at 30°C (20). E. coli strains were grown in LM
medium (12) at 37°C. The following antibiotics were used in the selective media:
ampicillin, 50 g/ml; kanamycin, 50 g/ml; and chloramphenicol, 50 g/ml.
Antibiotic susceptibility assay. The MIC of OA was determined by using the
sequential dilution method. A total of 102 freshly grown cells of the tested
B. glumae strain were incubated on an OA-containing PY agar medium at 30°C
for 2 days. The lowest concentration of OA, which completely inhibited growth,
was defined as the MIC.
DNA manipulations. Plasmid and chromosomal DNA isolation, restriction
mapping, cloning, subcloning, Southern blot hybridization, and PCR were per-
formed according to standard procedures (33). Restriction enzymes were ob-
tained from TaKaRa, Otsu, Japan. B. glumae was transformed by electroporation
as described by Allen et al. (1). Double-stranded DNA sequencing templates
were prepared with the GenElute plasmid miniprep kit (Sigma, St. Louis, Mo.).
DNA sequences were determined by using an Automated DNA sequencer
model 373 (Applied Biosystems, Tokyo, Japan), and analyzed by using DNASIS-
Mac software (Hitachi Software Engineering, Yokohama, Japan).
Cloning of the gyrA gene. To create a B. glumae Pg-10 genomic library, the
Pg-10 DNA genome was digested with BamHI, and 8 to 10-kb DNA fragments
were collected with sucrose density gradient centrifugation. The DNA fragments
were ligated into the BamHI site of pBluescript KS (Stratagene, La Jolla, Calif.)
and transformed into E. coli DH5 to create a Pg-10 genomic library.
To probe the gyrA gene from the Pg-10 genomic library, the following primers
were designed based on putative conserved sequences of gyrA from N. gonor-
rhoeae, N. meningitidis, and Ralstonia solanacearum to amplify an internal 338-bp
gyrA DNA fragment: 5-TACAAGAAGTCGGCGCG-3 (gyrA1) and 5-GCG
ATCCCGGACGAGCC-3 (gyrA2). PCR amplification was performed with 1
cycle of 94°C for 2 min, 25 cycles of 94°C for 1 min, 60°C for 1 min, and 72°C for
30 s by using a thermal cycler (TaKaRa). The resulting amplified 338-bp DNA
TABLE 1. Strains and plasmids used in this study
Strain or
plasmid Relevant characteristics
Source or
reference
Strains
E. coli
DH5 recA1 endA1 gyrA96 thi-1 hsdR17supE44 (lac)U169(80lacM15) 12
Pg-10–GyrA Holding pGYRA10 This study
B. glumae
Pg-10 Wild type 17
FU13 Wild type This study
M3 Wild type This study
Pg-7 Wild type 17
Pg-15 Wild type 17
Pg-10G Recombinant of Pg-10 with 3.9-kb DNA fragment of pGYRA-S; Kmr This study
FU13G Recombinant of FU13 with 3.9-kb DNA fragment of pGYRA-S; Kmr This study
M3G Recombinant of M3 with 3.9-kb DNA fragment of pGYRA-S; Kmr This study
Pg-7G Recombinant of Pg-7 with 3.9-kb DNA fragment of pGYRA-S; Kmr This study
Pg-15G Recombinant of Pg-15 with 3.9-kb DNA fragment of pGYRA-S; Kmr This study
Pg-10R Recombinant of Pg-10 with Ser83Arg substitution in GyrA; Kmr This study
Pg-10I Recombinant of Pg-10 with Ser83Ile substitution in GyrA; Kmr This study
FU13RS Recombinant of FU13 with Arg83Ser substitution in GyrA; Kmr This study
M3IS Recombinant of M3 with Ile83Ser substitution in GyrA; Kmr This study
Pg-7RS Recombinant of Pg-7 with Arg83Ser substitution in GyrA; Kmr This study
Pg-15IS Recombinant of Pg-15 with Ile83Ser substitution in GyrA; Kmr This study
Plasmids
pBluescript KS Ampr Stratagene
pGEM-T Ampr Promega
pHSG398 Cmr TaKaRa
pUCK191 pUC19 derivative containing the Kmr gene 36
pCUD800 sacB; Kmr 10
pHSG398RI pHSG398 derivative This study
pGYRA-QRDR 338-bp DNA fragment including gyrA-QRDR from Pg-10 in pGEM-T This study
pGYRA10 8.7-kb DNA fragment including gyrA from Pg-10 in pBluescript KS
pGYRA-1 5.1-kb ApaI/BamHI fragment of pGYRA10 in pBluescript KS This study
pGYRA-2 2.5-kb BamHI/KpnI fragment of pGYRA-1 in pHSG398RI This study
pGYRA-3 1.4-kb Kmr gene in pGYRA-2 This study
pGYRAKm 2.6-kb KpnI fragment of pGYRA-1 in pGYRA-3 This study
pGYRA-S 2.6-kb sacB of pGYRAKm This study
pGY-R2 1.2-kb RI-KpnI-Arg fragment substituted for the EcoRI/KpnI fragment in pGYRA-2 This study
This study
pGY-I2 1.2-kb RI-KpnI-Ile fragment substituted for the EcoRI/KpnI fragment in pGYRA-2 This study
pGY-R2Km 1.4-kb Kmr gene in pGY-R2 This study
pGY-I2Km 1.4-kb Kmr gene in pGY-I2 This study
pGYRA-R 2.6-kb sacB in pGY-R2Km This study
pGYRA-1 2.6-kb sacB in pGY-I2Km This study
pGYRA-7 2.6-kb sacB and 1.4-kb Kmr gene and 1.2-kb DNA fragment amplified by recombinant PCR from Pg-7 in pGYRA-2 This study
pGYRA-13 2.6-kb sacB and 1.4-kb Kmr gene and 1.2-kb DNA fragment amplified by recombinant PCR from FU13 in pGYRA-2 This study
pGYRA-15 2.6-kb sacB and 1.4-kb Kmr gene and 1.2-kb DNA fragment amplified by recombinant PCR from Pg-15 in pGYRA-2 This study
pGYRA-3 2.6-kb sacB and 1.4-kb Kmr gene and 1.2-kb DNA fragment amplified by recombinant PCR from M3 in pGYRA-2 This study
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fragment was cloned into pGEM-T (Promega, Madison, Wis.) to create pGYRA-
QRDR. The plasmid was used as a template in the following PCR. To probe gyrA
from the Pg-10 genomic library, Southern blot hybridization was performed by
using a digoxigenin-labeled DNA probe (Roche Molecular Biochemicals, Indi-
anapolis, Ind.) PCR amplified with gyrA1 and gyrA2 according to the manufac-
turer’s protocol. The resultant positive transformant, Pg-10–GyrA, held a plasmid
pGYRA10 containing an 8.7-kb insert (Fig. 1), which was used to sequence gyrA.
Recombination of OA-resistant B. glumae field isolates with gyrA from Pg-10.
To create recombinants from the OA-resistant B. glumae field isolates with gyrA
from Pg-10, pGYRA10 was partially digested with ApaI and a resulting 8.1-kb
fragment, including gyrA, was self-ligated to create pGYRA-1. Plasmid pHSG398
(TaKaRa) digested with EcoRI was blunt ended with a T4 DNA polymerase
(TaKaRa) and self-ligated to create an EcoRI site-deficient pHSG398RI. A
2.5-kb BamHI/KpnI fragment was subcloned from pGYRA-1 into pHSG398RI
to create pGYRA-2. A 1.4-kb KpnI-DNA fragment containing a kanamycin
resistance (Kmr) gene from pUCK191 (36) was blunt ended by T4 DNA poly-
merase and inserted into a blunt-ended pGYRA-2 EcoRI site to create pGYRA-
3. A 2.6-kb KpnI fragment from pGYRA-1 was ligated into KpnI site of pGYRA-3
to create pGYRAKm. A 2.6-kb BamHI/PstI fragment containing sacB from
pUCD800 (10) was blunt ended by T4 DNA polymerase and inserted into the
blunt-ended pGYRAKm BamHI site to create pGYRA-S. The plasmid was
electroporated into the cells of 25 field isolates, and the resultant kanamycin and
sucrose-resistant recombinants were selected. Southern blot analysis was per-
formed to verify correct insertion of 3.9-kb DNA fragment containing the Kmr
gene in the gyrA locus in the isolates genetic backgrounds (data not shown).
DNA gyrA sequencing. To determine the DNA sequences of gyrA from B. glu-
mae field isolates FU13, M3, Pg-7, and Pg-15, a 2,708-bp gyrA-containing DNA
fragment was PCR amplified from chromosomal FU13, M3, Pg-7, and Pg-15
DNA by using gyrA2 and gyrA2 (Table 2), designed based on the nucleotide
sequences of Pg-10 gyrA. PCR amplification was performed with 1 cycle of 94°C
for 2 min, 25 cycles of 94°C for 1 min, 63°C for 1 min, and 72°C for 3 min. The
DNA sequences of the amplified products were analyzed by using primers de-
signed based on the DNA sequences of gyrA from Pg-10 (Table 2).
DNA sequencing of the QRDR in gyrA. To analyze the DNA sequences of the
QRDRs in B. glumae field isolate gyrA, a 338-bp DNA fragment was PCR amplified
from the chromosomal DNA of field isolates by using gyrA1 and gyrA2 primers. The
DNA sequences of the PCR products were analyzed by using gyrA1 and gyrA2.
Ser83Arg and Ser83Ile substitutions in the GyrA of Pg-10. The single point
mutations corresponding to Ser83Arg and Ser83Ile substitutions in the GyrA of
Pg-10 were introduced into a 1.2-kb DNA fragment containing gyrA-QRDR from
chromosomal Pg-10 DNA by using recombinant PCR as follows. DNA frag-
ments, RI-Kpn-Arg and RI-Kpn-Ile fragments with Ser83Arg and Ser83Ile GyrA
substitutions, respectively, were synthesized by PCR with two pairs of primers: (i)
a forward primer 5-GCGAATTCGGGGAGGGCGCG-3 (RI-gyrA) and a re-
verse primer X and (ii) a forward primer Y and a reverse primer 5-GGGGTA
CCTCGCCGCGCTTG-3 (Kpn-gyrA). The X and Y primers are presented in
Table 3. PCR amplification was performed with 1 cycle of 94°C for 2 min, fol-
lowed by 5 cycles of 94°C for 1 min, 57°C for 1 min, and 72°C for 1 min; and finally
with 20 cycles of 94°C for 1 min, 61°C for 1 min, and 72°C for 1 min. Each PCR
product purified by agarose gel electrophoresis was mixed and then PCR amplified
with the RI-gyrA and Kpn-gyrA primers. PCR amplification was performed with
1 cycle of 94°C for 2 min, followed by 25 cycles of 94°C for 1 min, 61°C for 1 min, and
72°C for 1 min. RI-Kpn-Arg and RI-Kpn-Ile fragments were digested with EcoRI
and KpnI and then substituted into EcoRI/KpnI-digested pGYRA-2 fragments to
create pGY-R2 and pGY-I2, respectively. A 1.4-kb KpnI-DNA fragment containing
the Kmr gene from pUCK191 was blunt ended by T4 DNA polymerase and inserted
into the blunt-ended pGY-R2 and pGY-I2 EcoRI sites to create pGY-R2Km and
pGY-I2Km, respectively. A 2.6-kb PstI- and BamHI-digested DNA fragment con-
taining sacB from pUCD800 was blunt ended by T4 DNA polymerase and ligated
into the blunt-ended pGY-R2Km and pGY-I2Km KpnI sites, as described above,
to create pGYRA-R and pGYRA-I, respectively. These plasmids were electro-
porated into Pg-10 cells, and the resultant Kmr and sucrose-resistant recombi-
nants, Pg-10R and Pg-10I, were selected. DNA sequencing of PCR-amplified
DNA fragments by using gyrA2 and gyrA2 as primers were performed to
verify correct substitution of gyrA in Pg-10R and Pg-10I (data not shown).
Arg83Ser and Ile83Ser substitutions in the GyrA of OA-resistant field iso-
lates. To introduce Arg83Ser and Ile83Ser substitutions into the GyrA of Pg-7
and FU13 and of Pg-15 and M3, single point mutations corresponding to these
amino acid substitutions were introduced into 1.2-kb DNA fragments containing
gyrA-QRDR from isolate chromosomal DNA by using recombinant PCR with
Ser-Recom- and Ser-Recom (Table. 3), as described previously for Ser83Arg
and Ser83Ile substitutions in Pg-10 GyrA, to create pGYRA-7 and pGYRA-13
and to create pGYRA-15 and pGYRA-3, respectively. These plasmids were
electroporated into Pg-7, FU13, Pg-15, and M3 cells, and the resultant Kmr and
sucrose-resistant recombinants—Pg-7S, FU13S, Pg-15S, and M3S, respectively—
were selected. DNA sequences of PCR-amplified DNA fragments with gyrA2
and gyrA2 as primers were performed to verify correct substitution of gyrA in
Pg-7S, FU13S, Pg-15S, and M3S (data not shown).
Spontaneous in vitro mutants resistant to OA from Pg-10. To isolate sponta-
neous OA-resistant mutants from Pg-10, Pg-10 was incubated in a PY medium for
24 h and washed three times with sterilized water by centrifugation at 10,000 g for
30 s. The pellet was suspended in sterilized water, and the bacterial density was
adjusted to 1.0  108 CFU/ml. The suspension was spread onto a PY agar
medium containing 1.0 g of OA/ml, followed by incubation at 30°C for 3 days.
Determination of GyrA83 by using mismatch amplification mutation assay
PCR. To detect GyrA83 substitutions of the spontaneous OA-resistant mutants
obtained in vitro, the forward primers 5-CATCCGCACGGCGACAGC-3
(gyrA-Ser), 5-CATCCGCACGGCGACAGR-3 (gyrA-Arg), and 5-CATCCG
CACGGCGACAT-3 (gyrA-Ile) and a reverse primer R4 (5-GCGATCCCGG
ACGAGCC-3) were used in the MAMA PCR (27). PCR amplification was
performed with 1 cycle of 94°C for 4 min, followed by 25 cycles of 94°C for 1 min,
65°C for 1 min, and 72°C for 30 sec. Then, 9-l aliquots of each PCR product
were loaded onto horizontal, 2.0% TAE agarose gels and stained with ethidium
bromide for detection of 293-bp DNA fragments after electrophoresis.
FIG. 1. Physical map of pGYRA10, including gyrA from the geno-
mic DNA of B. glumae Pg-10. The arrow represents the localization
and orientation of the gyrA open reading frame.
TABLE 2. Primers used to obtain the nucleotide sequences of gyrA
Primer Sequence
gyrA2 .......................................5-GCGGTCCCGTCTTCGCTCCG-3
gyrA2 .......................................5-GTTGCACCGCCGGGCGCGAC-3
gyrA2....................................5-ATGCTGGTCGACGGTCAGGG-3
gyrA3 .......................................5-CACCATCTGCTCGCGAATCC-3
gyrA4 .......................................5-GACATCCGCGACGAGTCCGA-3
gyrA5 .......................................5-ATGCGTCTGCAGCGCCTGAC-3
gyrA21..................................5-CACGATCTACGAACTGCG-3
gyrA23..................................5-CAGATGAAGGAAGACGACTG-3
gyrA24..................................5-ATGACGGCGACTTCCTGATCGG-3
gyrA25..................................5-TCACGGAATACACGCGTCACGG-3
TABLE 3. Templates and primers used for recombinant PCR to
introduce amino acid substitutions at position 83 in
the GyrA of B. glumae field isolates
Amino acid
substitution
at GyrA83
Genomic
DNA used
as a
template
Primera Sequenceb
Ser83Arg Pg-10 X 5-CGTAGACCGCTCTGTCGCCGTG-3
Y 5-CACGGCGACAGAGCGGTCTACG-3
Ser83Ile Pg-10 X 5-CGTAGACCGCGATGTCGCCGTG-3
Y 5-CACGGCGACATCGCGGTCTACG-3
Arg83Ser Pg-7, Fu13 X 5-CGTAGACCGCGCTGTCGCCGTG-3
Y 5-CACGGCGACAGCGCGGTCTACG-3
Ile83Ser Pg-15, M3 X 5-CGTAGACCGCGCTGTCGCCGTG-3
Y 5-CACGGCGACAGCGCGGTCTACG-3
a Primers X and Y are complementary and correspond to the gyrA sequence of
isolates from which the genomic DNA used as template was isolated.
b Position of the sequences was at 238 to 259 in the gyrA of each isolates.
Underlined letters indicate nucleotide changes.
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Nucleotide sequence accession numbers. Pg-10, Pg-7, Pg-15, FU13, and M3
gyrA nucleotide sequences were assigned DDBJ accession numbers AB121693,
AB121694, AB121695, AB121693-6, and AB121697, respectively.
RESULTS
MIC of OA in B. glumae field isolates. Thirty-five B. glumae
field isolates obtained from diseased seedlings grown from
OA-treated seeds were collected from five prefectures in Ja-
pan. Based on the OA MICs, these isolates were divided into
three groups (Table 4): OA-sensitive isolates (OSs; MIC 	 0.5
g/ml), moderately resistant isolates (MRs; MIC 	 50 g/ml)
and high resistant isolates (HRs; MIC  100 g/ml).
Cloning of the gyrA gene. It has been reported that gyrA
mutations confer quinolone resistance in most clinical isolates
of gram-negative bacteria, such as E. coli, Methylovorus sp., and
N. gonorrhoeae (43). Moreover, many quinolone-resistant gram-
negative bacteria, whose resistance to chemicals results from
gyrA mutations, can be complemented by quinolone sensitivity
with the introduction of the wild-type allele (31). To determine
whether resistance to OA in B. glumae field isolates results
from gyrA mutations, gyrA was cloned from the genomic DNA
of an OS, B. glumae Pg-10, and recombinants of the isolates
with gyrA from Pg-10 were created with marker exchange.
Using conserved primers, gyrA1 and gyrA2, based on the
conserved sequences of gyrA in the 
-subclasses of proteobac-
teria, N. gonorrhoeae MS11, N. meningitidis Z2491, Methylo-
vorus sp. strain SS1, and R. solanacearum GMI1000, a 338-bp
DNA fragment was PCR amplified from Pg-10. A clone con-
taining a pGYRA10 (Fig. 1) was selected from the Pg-10 ge-
nomic library with Southern hybridization by using the ampli-
fied DNA fragment as a probe, and nucleotide sequences of
the 8.7-kb insert were determined (Fig. 2A). The open reading
frame of Pg-10 gyrA consisted of 2,610 nucleotides, with 56.2,
56.4, 65.9, and 78.1% identities to the gyrA of N. gonorrhoeae
MS11, N. meningitidis Z2491, Methylovorus sp. strain SS1, and
R. solanacearum GMI1000, respectively. The deduced amino
acid sequence of GyrA showed 50.2, 50.1, 65.7, and 81.4% iden-
tities to GyrAs of N. gonorrhoeae MS11, N. meningitidis Z2491,
Methylovorus sp. strain SS1, and R. solanacearum GMI1000, re-
spectively, and had a homologous region consisting of 40 ami-
no acids with 95.0, 90.0, and 97.5% identities to the QRDRs of
E. coli K-12, N. gonorrhoeae MS11, and Methylovorus sp. strain
SS1, respectively (Fig. 2B).
Recombination of OA-resistant B. glumae field isolates with
gyrA from Pg-10. To examine the dependency of field isolate
OA resistance on gyrA mutations, recombinants from 24 OA-
resistant field isolates (6 MRs and 18 HRs) were created with
marker exchange with gyrA-containing pGYRA-S from Pg-10.
The insertion specificity was verified by Southern blot analysis
FIG. 2. Deduced amino acid sequence of GyrA in B. glumae Pg-10 (A) and comparisons of the deduced amino acid sequences of the QRDR
of GyrA (B). The underlined sequences are involved in QRDR.
TABLE 4. MICs of OA in B. glumae field isolates and
recombinants of the isolates with gyrA from B. glumae
Pg-10 and deduced amino acid residues at position
83 in the GyrAs of these isolates
MIC
of OA
(g/ml)
Deduced amino acid
residue at position
83 in GyrA (codon)
Isolatesa
0.5 Ser (AGC) Pg-10, Pg-12, 0112
50 Arg (AGA or AGG) Pg-5, Pg-6, Pg-7, Pg-8, Pg-9, Pg-17,
FU11, FU13, FU15, FU22
100 Ile (ATC) 0101, Pg-14, Pg-15, M1, M3, M6, M8,
M9, M10, IZUMI, TONDA, H91,
H92, H93, H94, H95, H101, H102
a The MICs of OA in recombinants of underlined and italic isolates are 0.5 and
5.0 g/ml, respectively.
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(data not shown). The MICs of OA in the 12 field isolate
recombinants (three MRs and nine HRs, S-type) and the other
12 field isolate recombinants (three MRs and nine HRs, MS-
type) were 0.5 and 5 g/ml, respectively (Table 4), suggesting
that recombination with gyrA from Pg-10 resulted in any of the
field isolates becoming OA susceptible. In particular, only gyrA
mutations were responsible for the OA resistance of S-type
isolates. On the other hand, MS-type isolates might have not
only gyrA mutations but other mechanisms that are involved in
OA resistance. The MIC of OA in the Pg-10 recombinants with
pGYRA-S was 0.5 g/ml.
DNA sequences of gyrA from B. glumae field isolates. To elu-
cidate the relationship between OA resistance and gyrA muta-
tions in B. glumae field isolates, the DNA sequences of gyrA
from an OS (Pg-10), MRs (Pg-7 and FU13), and HRs (Pg-15
and M3) were compared. The gyrA of each isolate was com-
posed of 2,610 nucleotides. An amino acid at position 497 in
the GyrAs of Pg-7, FU13, Pg-15, and M3 was Leu, although
that of Pg-10 was Met (Fig. 3). In addition, the amino acid at
position 83 of GyrA (GyrA83) in Pg-10 was Ser with anAGC
codon; however, in all MRs and all HRs it was Arg and Ile,
with AGA or AGG and ATC codons, respectively. These re-
FIG. 3. Deduced amino acid sequences of GyrA from B. glumae Pg-10, Pg-7, FU13, Pg-15, and M3. The underlined sequences are involved in
the QRDR.
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sults suggest that substitutions of GyrA83 located in QRDR
might be involved in OA resistance (Table 4).
GyrA83 involvement in the OA resistance of B. glumae field
isolates. To determine whether Ser83Arg and Ser83Ile substi-
tutions result in OA-resistant bacteria, a point mutation was
introduced into gyrA in Pg-10 with marker exchange. Pg-10R
and Pg-10I containing the GyrA83 substitution for Arg and an
Ile, respectively, were then created. Ser83Arg and Ser83Ile
substitution specificity in GyrA83 of Pg-10R and Pg-10I was
verified by DNA sequences of PCR-amplified DNA fragments
with gyrA2 and gyrA2 as primers (data not shown). The
MICs of OA for Pg-10R and Pg-10I were 50 and 100 g/ml,
respectively (Table 5), suggesting that Ser83Arg and Ser83Ile
substitutions result in moderate and high resistance to OA,
respectively.
To determine whether GyrA83 mutations in GyrA are in-
volved in B. glumae field isolate OA resistance, a point muta-
tion was introduced into gyrA in the S-type isolates (Pg-7 and
Pg-15) and MS-type isolates (FU13 and M3) with marker ex-
change. Then, Pg-5RS and FU13RS, or Pg-15IS and M3IS
containing an Arg83Ser or Ile83Ser GyrA83 substitution, re-
spectively, were created. GyrA83 substitution specificity in
Pg-5RS, FU13RS, Pg-15IS and M3IS was verified by DNA
sequences of PCR-amplified DNA fragments with gyrA2 and
gyrA2 as primers (data not shown). The MICs of OA for the
S-type recombinants (Pg-7RS and Pg-15IS) and MS-type re-
combinants (FU13RS and M3IS) were 0.5 and 5.0 g/ml,
which are similar to those for Pg-7S and Pg-15S, and FU13S
and M3S, respectively (Table 5). These results suggest that
GyrA83 mutations are commonly responsible for OA resis-
tance in B. glumae field isolates, and Leu497Met substitution in
GyrA may not be involved in the resistance to OA of field iso-
lates.
GyrA83 in spontaneous OA-resistant mutants from Pg-10.
To determine whether factors other than GyrA83 mutations
might be involved in OA resistance, 89 spontaneous OA-resis-
tant mutants (59 MRs and 30 HRs) of Pg-10 were isolated
from Pg-10 grown on medium containing 1.0 g of OA/ml.
Analysis of single nucleotide polymorphisms with gyrA-Ser,
gyrA-Arg, or gyrA-Ile and R4 primers showed that GyrA83 in
54 MRs and 24 HRs was Ser (Table 6). In five MRs and four
HRs it was Arg, and in two HRs it was Ile, suggesting that the
OA resistance of these spontaneous mutants does not neces-
sarily depend only on GyrA83 mutations.
DISCUSSION
Two main mechanisms of quinolone resistance in gram-
negative bacteria were established: alterations in the quinolone
targets, and decreased bacterial quinolone uptake (32). Amino
acid substitutions involved in the development of quinolone
resistance in E. coli have been described for GyrA/GyrB and
ParC/ParE. A similar proportion of gyrA and gyrB mutations
was observed for the presence of DNA gyrase mutations in
quinolone-resistant E. coli strains obtained in vitro (31), whereas
clinical isolate studies showed an exclusive prevalence of gyrA
mutations (9, 31, 38). In the present study, amino acid analysis
of QRDR in GyrA suggests that the GyrA83 of OA-resistant
B. glumae field isolates is responsible for the level of OA re-
sistance. Ser83Arg-Ser83Ile and Arg83Ser-Ile83Ser GyrA sub-
stitutions in OA-sensitive and OA-resistant isolates, respec-
tively, show that bacterial OA resistance depends on GyrA83
substitutions. Therefore, GyrA83 substitutions are commonly
responsible for OA resistance in B. glumae field isolates. On
the other hand, resistance to OA in Pg-10 mutants in vitro did
not necessarily depend on GyrA83 substitutions. This evidence
suggests that only OA-resistant bacteria with Ser83Arg and
Ser83Ile substitution might retain their ability to survive on
rice plants grown in paddy fields and cause diseases on rice
plants applied with OA.
Each GyrA dimmer subunit contains a short recognition
helix on its presumed DNA-binding surface (10). The major
quinolone resistance mutations map on the exposed surface of
this helix at amino acids 83 and 87 in E. coli protein (6, 31, 32).
Studies with purified DNA gyrase indicate that such mutations
reduce drug binding (4, 39, 42). Since two recognition helices
occur per GyrA dimmer (30) and biochemical studies indicate
a stoichiometry of two quinolones per complex (5), it is likely
that one quinolone binds to each recognition helix. Inspection
of the amino acid changes conferring resistance at these posi-
tions reveals that the electronegative character of Ser at posi-
tion 83 and Asn at position 87 is lost, mainly by mutations to
the hydrophobic residues (4, 34). Substitution at Ser-83 to Ile,
which is a hydrophobic residue, in the GyrA of B. glumae Pg-10
resulted in strong OA resistance, supporting data from GyrA
substitutions of E. coli. Since Arg is a basic residue and tends
to be located on the surface of protein molecules, Ser83Arg
substitutions might cause weak changes in the structure of the
GyrA-GyrA surface and reduce the binding activity of the
TABLE 5. MICs of OA in recombinants at position 83 in the
GyrAs of B. glumae Pg-10, Pg-7, Pg-15, M3, and FU13
B. glumae
straina
Amino acid residue at
position 83 in GyrA
MIC of OA
(g/ml)
Pg-10 Ser 0.5
Pg-7 Arg 50
FU13 Arg 50
Pg-15 Ile 100
M3 Ile 500
Pg-10R Arg 50
Pg-10I Ile 100
Pg-7S Ser 0.5
FU13S Ser 5.0
Pg-15S Ser 0.5
M3S Ser 5.0
a Pg-10R and Pg-10I are recombinants of Pg-10 in which the amino acid
residues at position 83 of GyrA were substituted by Arg and Ile, respectively, via
marker exchange. Pg-7S, FU13S, Pg-15S, and M3S are recombinants of Pg-10 in
which the amino acid residue at position 83 of GyrA was substituted by Ser via
marker exchange.
TABLE 6. Amino acid residues of GyrA at position 83 in
spontaneous OA-resistant mutants from B. glumae Pg-10
MIC of OA
(g/ml)
Amino acid residue at
position 83 of GyrA
No. of
isolates
50 Ser 54
Arg 5
100 Ser 24
Arg 4
Ile 5
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GyrA dimmer to OA, resulting in moderate OA resistance.
The codon at Ser-83 in the GyrA of OA-sensitive field isolates
is AGC, and changes in this codon to AGA or AGG and ATC
resulted in Arg-83 and Ile-83, respectively. A change into AGT
results in Ser, and changes into AAC and ACC result in Asn
and Thr, respectively. Since these amino acid residues are elec-
tronegative residues like Ser, these codon changes might not
result in changes in GyrA-GyrA structure or OA resistance.
Baquero et al. suggested that a dangerous concentration
range exists in which mutants are most frequently selected (2,
3). Furthermore, Drlica et al. (8) demonstrated that a thresh-
old (mutant prevention concentration [MPC]) could be de-
fined for restricting resistance development when the selection
of resistant mutants is controlled by quinolone concentrations.
A wide variety of mutants, including both target and putative
efflux variants (7, 43), are selectively amplified in the concen-
tration gap (the mutant selection window) between the MPC
and the lowest concentration that inhibits growth of the ma-
jority of susceptible bacteria (MIC). At concentrations greater
than the MPC, two resistance mutations are expected to be
necessary for growth. According to this theory, the MPC and
MIC of OA for B. glumae are 10 g/ml (data not shown) and
0.5 g/ml (Table 4), respectively. Ser83Arg and Ser83Ile sub-
stitutions in the GyrA of Pg-10 result in moderate and high
resistance to OA, respectively, and the MICs of OA in the
recombinants are 50 and 100 g/ml. Analysis with recombi-
nants with gyrA from Pg-10 shows that OA resistance in 12 of
the 24 isolates depended only on GyrA mutations. Moreover,
Arg83Ser and Ile83Ser substitutions in the GyrAs of Pg-7 and
Pg-15, respectively, show that the OA resistance of these iso-
lates depends only on the GyrA83 substitution. Most rice farm-
ers in Japan apply 200 g of OA/ml to heading rice plants by
foliar application and immerse rice seeds in a 1,000-g/ml
solution of OA for 24 h or a 10,000-g/ml solution for 20 min,
according to protocols described in the literature (18). Since
the solubility of OA in water is 3.2 g/ml (18), B. glumae on
rice plants grown in paddy fields might theoretically be ex-
posed to OA solutions at concentrations lower than the MPC.
Therefore, the OA resistance of these B. glumae field isolates
depends on a single amino acid mutation at position 83 in
GyrA.
On the other hand, the resistance to OA of the other 12
isolates might involve other mechanisms in addition to the
GyrA83 substitution. There is no difference in the deduced
amino acid sequences of QRDR in parC of all field isolates (Y.
Maeda, unpublished data). In addition, the role of amino acid
substitutions in ParE, which result in the development of quin-
olone resistance in clinical isolates of gram-negative bacteria,
appear to be irrelevant (9), and alterations in the GyrB of
E. coli, which result in quinolone resistance, have been de-
scribed at positions 426 and 447 (41). However, it remains
unclear whether ParE and GyrB alterations in B. glumae are
involved in the resistance conferred by other mechanisms. On
the other hand, although the MIC of OA for recombinants
with Ser83Ile in the GyrA of Pg-10 was 100 g/ml, that for
Pg-14, of which GyrA83 was Ile, was 1,000 g/ml. These
results suggest that mechanisms other than GyrA83 substitu-
tion might be involved in the development of increased OA
resistance in Pg-14. In our previous study of highly OA resis-
tant B. glumae with an MIC of OA of 1,000 g/ml, a DNA
fragment containing one open reading frame involved in the
development of increased OA resistance conferred by GyrA
alterations was isolated (20). This DNA fragment does not
confer resistance to OA on OA-sensitive B. glumae. These
findings suggest that other mechanisms might be involved in
the development of increased OA resistance in isolates with
GyrA83 substitutions.
Although antibiotic pressure usually reduces bacterial diver-
sity by favoring those that are better adapted (29), Low et al.
(26) demonstrated that, in the long term, antibiotic treatment
might provoke the diversification of antibiotic resistance. In
Japan, since its registration 15 years ago, OA has been used for
disease control three times per rice cultivation season. Re-
cently, it was reported that an OA-resistant Erwinia amylovora
was isolated from pear orchards in Israel, where since 1998 the
number of OA applications was one to three sprays per season
(28). Manulis et al. (28) demonstrated that the use of an at-risk
compound where large bacterial populations exist should be
avoided and that the number of risk compound applications
should be reduced. B. glumae naturally exists saprophytically
on roots, stem bases, and the lower leaf sheaths of rice plants
(15). Bacteria existing on the flag leaf sheaths invade the flow-
ering spikelets and utilize intermediate sugars in the biosyn-
thesis of grain starch in these spikelets to remarkably multiply
during 5 days after flowering (19). Therefore, OA applications
to heading rice plants have shown a high efficacy in the control
of bacterial grain rot of rice (15). However, applications to rice
plants after heading results in reduced efficacy, since the bac-
teria in the spikelets have already proliferated vigorously.
Moreover, OA applications to high populations of bacteria
might result in the development of OA-resistant bacteria. The
results of the present study suggest that several mechanisms
are involved in increased resistance to OA in B. glumae field
isolates with GyrA83 substitution. These evidences suggest
that high resistance to OA might develop among MRs and
HRs with GyrA83 substitutions, thus infecting rice plants,
through selection by multiple OA applications.
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